Accelerating Disease Modeling and Drug Discovery Using 3D Bioprinting Technologies
-
You must log in to register
- Non-member - Free!
- Member - Free!
- Student Member - Free!
- Lab Member - Free!
In this presentation, we will explore how bioprinting technologies address key challenges within drug discovery and drug screening. Bioprinting enables the creation of complex, heterogeneous structures that better mimic in vivo tissue. By precisely controlling the placement and composition of different cell types, scientists can create 3D biomimetic models with more realistic cell-cell interactions, gradients, and microenvironments. Standardized workflows can be developed, reducing time-consuming and repetitive tasks, and enabling more consistent data gathering.
Join us to learn about the exciting potential of bioprinting technology in advancing disease modeling and drug discovery.
Pierre-Alexandre Laurent
Senior Field Application Scientist, Light-based Bioprinting Specialist
CELLINK
He is Senior Field Application Scientist and Light-based Bioprinting Specialist at CELLINK, company leader in bioprinting technologies.
After a PhD on the role of PI3-Kinases on the platelet functions and thrombus formation using microfluidic and videomicroscopy technics, he dedicated his postdoc research (Pavia University, Italy) on the development of 3D bone marrow models for the study of thrombocytopenia and ex-vivo platelet production using silk fibroin biomaterial and 3D bioprinting approach.